2024 Fall Senior Executive Conference Sunday, September 29 (4pm) - Tuesday, October 1, 2024 (9:30am US/Pacific) The Ritz-Carlton Half Moon Bay One Miramontes Point Road [map] Half Moon Bay, CA

The registration period for this meeting has ended.

Registration is closed for this Conference. Please contact Carol Starke (cstarke@thealda.org) with any questions.

For more information and FAQs, please check out our webpage at http://www.thealda.org/halfmoonbay2024!

The Fall Senior Executives Conference is one of our semi-annual meetings designed for member company C-suite executives, presidents and their senior executive teams. Each meeting focuses on emerging trends and business strategies and offers great insights and advice, along with many opportunities for dialogue with other senior executive attendees.

Past meetings have focused on proteomics, artificial intelligence, immunology, the transformation of healthcare and trends in pharma. We include a global economic and financial outlook to complement each topical program.

This year's conference will focus on “Innovations in Multi-omics”, exploring the integration of diverse biological data sets such as genomics, proteomics, metabolomics, and more. This interdisciplinary approach offers invaluable insights into complex biological systems, revolutionizing personalized medicine, drug discovery, and diagnostics.

Sunday, September 29
Welcome reception and seated dinner with guest speaker:

Chuck Todd
Chief Political Analyst at NBC
Moderator of Meet the Press from 2014-2023

Elections and Beyond: A Debrief on the Political Landscape

Chuck Todd is NBC News’ chief political analyst and, from 2014-2023, served as the revered moderator of Meet the Press. Renowned for his trusted voice during multiple US elections and his role as a co-moderator for two of NBC’s presidential primary debates, Chuck brings unparalleled expertise in political analysis.

In his session, he’ll highlight key political trends and their potential impacts on global markets, offering valuable perspectives for attendees on navigating the political landscape and its implications for the industry. Whether you’re looking to understand the latest political dynamics or seeking to gain strategic foresight, Chuck’s analysis will be invaluable.

Monday, September 30
“Multi-omics” programming all day.

From Data to Discovery: Harnessing the Power of Multi-omics
Presented by:
Michael Snyder, Ph.D.
Chair, Dept. of Genetics, Director, Center for Genomics and Personalized Medicine
Stanford Medicine

Dr. Mike Snyder--a leading expert in the field of genomics and personalized medicine-- will present a comprehensive overview of the multi-omics landscape. This session will explore the relevance of multi-omics to enhancing our understanding of complex biological systems and diseases, offering insights into how this integrative approach can lead to more precise and predictive healthcare solutions. Dr. Snyder will also discuss the impact of multi-omics on drug development, disease diagnosis, and personalized treatment plans, highlighting practical applications that could benefit executive members and their companies.

Revolutionizing Disease Understanding with Multi-Omics Research
Presented by:
Gary J. Patti, Ph.D.
Michael & Tana Powell Professor, Washington University, St. Louis and
Founder, Panome Bio
Dr. Gary Patti, a leading expert in metabolomics and key member of the NIH Multi-Omics for Health and Disease Consortium, will discuss the transformative potential of multi-omics research. This NIH consortium advances the generation and analysis of multi-omics data for human health research. As principal investigator of this consortium, Dr. Patti leads a central production center that functions as a hub for multi-omics analyses for materials from consortium members at each of six disease study sites identified by the NIH. Dr. Patti will share insights into how these efforts are revolutionizing disease understanding, with significant implications for ALDA member companies.

Gary J. Patti, Ph.D., is a leading researcher in the field of metabolomics and the Michael and Tana Powell Professor at Washington University in St. Louis, where he holds appointments in the department of chemistry and the department of medicine. Dr. Patti’s research focuses on developing and applying both mass spectrometry-based and NMR-based metabolomics technologies to enhance our understanding of human health. Dr. Patti is also founder of Panome Bio and has helped advance the field of metabolomics through the development of gold-standard software tools, commercial benchmarking kits, and NIH led trials.

Applications of AI in Multi-omics Analysis
Presented by:
Dr. Russ Altman, PhD
Kenneth Fong Professor of Bioengineering, Genetics, Medicine, Biomedical Data Science, and (by courtesy) Computer Science
Past chairman of the Bioengineering Department
Stanford University

Dr. Russ Altman, a distinguished professor at Stanford University and a pioneer in the field of bioinformatics, will delve into the intersection of artificial intelligence and multi-omics during his session. Drawing from his wide-ranging expertise, attendees can anticipate gaining invaluable insights into the transformative potential of AI-driven approaches in deciphering complex biological data. Don’t miss this opportunity to explore the cutting-edge applications of AI in multi-omics analysis with one of the foremost experts in the field.

Multi-omics Integration in Drug Discovery & Development
Presented by:
Mohit Jain, Ph.D.
Founder & CEO
Sapient

Explore the transformative power of multi-omics in enhancing our understanding of human biology and its implications for health and disease over time. This session will delve into the innovative applications of multi-omics in drug discovery and development, highlighting its growing impact on the ALDA member community. Attendees will gain insights into the practical implications of multi-omics technologies for the industry and their businesses.

Dr. Mo Jain is a physician-scientist with an extensive background spanning two decades in medicine, physiology, mass spectrometry, and large-scale human discovery. Formerly the director of the Jain Laboratory at the University of California San Diego (UCSD), Dr. Jain founded Sapient in 2021 with the ambitious goal of revolutionizing drug discovery through human data that extends beyond the genome.

Tuesday, October 1
Keynote Session with guest speaker:

Dr. Jennifer Doudna

We’re honored to welcome Dr. Jennifer Doudna, PhD, as our esteemed keynote speaker. Dr. Doudna, a Nobel laureate honored in 2020 for her pioneering work in CRISPR technology, stands as a beacon of innovation in the field of genomics and molecular biology. As the co-inventor of CRISPR-Cas9 gene editing, her research has revolutionized our understanding of genetic engineering and its applications in medicine, agriculture, and beyond.

During her keynote session, Dr. Doudna will share invaluable insights from her experiences at the forefront of genomic innovation. From navigating ethical considerations in gene editing to harnessing CRISPR’s potential for transformative therapies, attendees can expect a thought-provoking discussion that delves into both the promise and the challenges of genomic advancements. With her engaging and approachable style, Dr. Doudna will inspire attendees to embrace innovation responsibly while charting the course for the future in our industry. This will be a truly enlightening session!

Related Web Pages and Sites:
More details and Conference FAQs!

Who Should Attend:

Our semi-annual meetings designed for member company C-suite executives, presidents and their senior executive teams.

Registration Fees: These fees are available through 09/28/2024
Name	Price	Available To
First Registrant	$2,795.00	Member
Additional Registrants	$2,295.00	Member

Cancellation and Other Policies:

**No refunds of Conference registration fees will be made for registration cancellations after Friday, September 20, however, if you must cancel, please remember that you are also responsible for canceling your hotel reservations.

For more information please contact:

Carol Starke
Manager, Meetings & Administration
Analytical, Life Science & Diagnostics Association (ALDA)
Phone: (703) 647-6361
Email: CStarke@thealda.org